| Finding a marker for chemotherapy-induced deafness: Professor Michael Hayden, in the Department of Medical Genetics, and Professor Bruce Carleton, in the Faculty of Pharmaceutical Sciences, identified genetic variations that predict whether an anti-cancer drug will cause deafness. Read Globe and Mail article |
 |